Page Number :5 Safety Assessment of CD19-Targeted CAR T Cells in Children with Acute Lymphoblastic Leukemia Jan 4 2026 - 07:15 Importance of BCG Vaccination at birth in Pediatric Patients with Chronic Granulomatous Disease after Hematopoietic Stem Cell Transplantation in Developing Countries Jan 4 2026 - 07:12 Tregs in allogeneic hematopoietic stem cell transplantation (allo-HSCT): Suppressing GVHD While Preserving GVL Jan 4 2026 - 07:10 Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine Jan 4 2026 - 06:26 Natural killer cell-based therapies in neuroblastoma Jan 4 2026 - 06:20 U.S. CRISPR & Cas Genes Market to Reach $5.1 Billion by 2034 Sep 13 2025 - 09:51 FDA Approves Qfitlia™ (fitusiran), the First siRNA Therapy for Hemophilia A and B Sep 6 2025 - 10:55 World-First 3D Printing Breakthrough Brings Cure for Type 1 Diabetes Closer Jul 14 2025 - 00:08 China’s First Gene-Editing Therapy for Beta-Thalassemia Receives FDA RMAT Designation Jul 11 2025 - 08:05 XellSmart Leads Global Breakthroughs in iPSC-Based Cell Therapie Jul 8 2025 - 09:46 1 2 3 4 5 6 7 8
Safety Assessment of CD19-Targeted CAR T Cells in Children with Acute Lymphoblastic Leukemia Jan 4 2026 - 07:15 Importance of BCG Vaccination at birth in Pediatric Patients with Chronic Granulomatous Disease after Hematopoietic Stem Cell Transplantation in Developing Countries Jan 4 2026 - 07:12 Tregs in allogeneic hematopoietic stem cell transplantation (allo-HSCT): Suppressing GVHD While Preserving GVL Jan 4 2026 - 07:10 Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine Jan 4 2026 - 06:26 Natural killer cell-based therapies in neuroblastoma Jan 4 2026 - 06:20 U.S. CRISPR & Cas Genes Market to Reach $5.1 Billion by 2034 Sep 13 2025 - 09:51 FDA Approves Qfitlia™ (fitusiran), the First siRNA Therapy for Hemophilia A and B Sep 6 2025 - 10:55 World-First 3D Printing Breakthrough Brings Cure for Type 1 Diabetes Closer Jul 14 2025 - 00:08 China’s First Gene-Editing Therapy for Beta-Thalassemia Receives FDA RMAT Designation Jul 11 2025 - 08:05 XellSmart Leads Global Breakthroughs in iPSC-Based Cell Therapie Jul 8 2025 - 09:46
Safety Assessment of CD19-Targeted CAR T Cells in Children with Acute Lymphoblastic Leukemia Jan 4 2026 - 07:15
Importance of BCG Vaccination at birth in Pediatric Patients with Chronic Granulomatous Disease after Hematopoietic Stem Cell Transplantation in Developing Countries Jan 4 2026 - 07:12
Tregs in allogeneic hematopoietic stem cell transplantation (allo-HSCT): Suppressing GVHD While Preserving GVL Jan 4 2026 - 07:10
Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine Jan 4 2026 - 06:26
China’s First Gene-Editing Therapy for Beta-Thalassemia Receives FDA RMAT Designation Jul 11 2025 - 08:05